$IBTA

Leach Bryan sold $309K of IBTA

Leach Bryan (CEO AND PRESIDENT) sold 9,326 shares of Ibotta, Inc. (IBTA) at an average of $33.09 ($32.67–$35.24, $0.31M total) across 4 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leach Bryan
Published Jul 8, 2026, 8:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
high confidence
Mentioned
$IBTA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The only new fact is the disclosed sale size, timing (2026-07-06), and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to change the fundamental outlook.

03

What to watch

The filing does not indicate why the sale occurred, and the weighted-average price range ($32.67 to $35.24) suggests execution across multiple trades rather than a single event-driven decision.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-07-08 after the 2026-07-06 sale execution.

Background

The article is an SEC Form 4 insider transaction for Ibotta, Inc., reported by CEO and President Leach Bryan.

Company-level read

Ticker impact

$IBTANeutralHigh confidence
Context

CEO and President Leach Bryan filed a Form 4 selling about $308.6K of Ibotta shares under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this filing.

Evidence & confidence

The disclosure is an open-market sale by an insider, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operating, financial, or regulatory information.

Market effects

No clear sector read-through from a single, small 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with insider expectations of near-term risk, so some traders may treat it as a mild caution signal.

Key entities

  • Ibotta, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Leach Bryan

    CEO and President, reported open-market sale of company shares.

Related articles

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease63026.htm EX-99.1 Document Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million